Mastering Viral Vectors: Customizing Vector Designs to Solve Neurological Diseases
Overview
Adeno-associated viruses (AAVs) have emerged as essential tools for delivering genetic material into tissues and engineering therapeutic cells. As gene and cell therapies advance, researchers optimize AAV design and enhance vector production to improve targeting, precision, and safety.
In this two-day symposium hosted by The Scientist, Application Scientist, Ajinkya Sase Ph.D, discusses how customized vector designs are driving breakthroughs in disease modeling, therapeutic development, and molecular interactions.
What you’ll learn
- How engineered AAV capsids can show improved cell targeting that are specific to neurological research.
- How Vector Biolabs can synthesize cell-type specific promoters of your choice -based on supplied preliminary data- for GOI expression.
- Various approaches to Overcoming Cargo limitations with Dual and Triple AAVs
Speaker
Ajinkya Sase Ph.D
Ajinkya Sase, Ph.D. is an Application Scientist at Vector Biolabs with over 20 years of experience in molecular and cellular biology. He is the primary scientific resource for customers—providing expert guidance on vector design, serotype selection, and project strategy. Before joining Vector Biolabs, Ajinkya was a Senior Scientist in Gene Therapy industry, leading AAV vector engineering from construct design to building pre-IND studies. He also held research roles at the University of Pennsylvania, USA and Medical University of Vienna, Austria. Ajinkya earned his Ph.D. from the Medical University of Vienna, Austria, where he developed new drugs targeting Dopamine Receptor to improve learning and memory. Known for his collaborative approach and problem-solving mindset, Ajinkya combines hands-on vector engineering expertise with a passion for helping researchers advance their gene therapy goals—whether optimizing small preclinical studies or scaling toward clinical development.